Emergence of OXA-72-producing Acinetobacter baumannii belonging to high-risk clones (CC15 and CC79) in different brazilian states by Pagano, Mariana et al.
The addition of an easy-to-use qualitative component to
hand hygiene compliance observations and consecutive
training efforts is important, given that <10% of all hand
disinfections were performed correctly in an observational
study by Tschudin-Sutter et al,1 who observed the 6-step
technique. Appropriate hand-surface coverage was reached in
only 7.9% of hand hygiene procedures observed by Park et al,2
despite a high rate of compliance with the correct indications.
Shah et al3 performed a video observation of hand washing.
Of 1,081 recordings, 403 (37.3%) were excellent, 521 (48.2%)
were acceptable, and 157 (14.5%) were unacceptable.
A limitation of our study is the lack of bacterial counts, but
the results of Riley et al,4 who showed no correlation between
hand coverage and bacterial counts with a 6-step technique
compared to a 3-step approach, had not been published at the
time of our experiment.4 Another limitation is the small
number of participants and the experimental setting of this
proof-of-principle study. However, we believe that based on
our results, the addition of dichotomous subjective quality
assessment using the parameters time and skin coverage
during live observation by experienced infection control staff is
feasible and could be a valuable addition to conventional hand
hygiene observation.
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Emergence of OXA-72-producing
Acinetobacter baumannii Belonging to
High-Risk Clones (CC15 and CC79) in
Different Brazilian States
To the Editor—Carbapenem resistance limits treatment
options and causes major therapeutic problems; it has been
continuously reported worldwide among Acinetobacter
baumannii isolates. Carbapenem resistance in A. baumannii is
frequently associated with Ambler class D carbapenemase,
mainly blaOXA-23. Until now, there have been only a few
reports of other oxacilinases, such as blaOXA-72, in Brazil.1
Multilocus sequence typing (MLST) seems to be a reliable tool
for investigating population structure and global A. baumannii
epidemiology. In Brazil, most carbapenem-resistant
blaOXA-23–producing A. baumannii have been associated
with clonal complexes CC79 and CC15.2 To the best of our
knowledge, our report here is the first report of the epidemic
clonal complex CC15 associated with A. baumannii carrying
blaOXA-72. Furthermore, we describe the spread of
table 1. Classifications of Observed Hand Disinfection Tests and Group-Specific Resultsa
A. Hand Hygiene Demonstrations
Variable Test 1 Test 2 Test 3 Test 4 Test 5
Time, s 32 12 29 31 32
Coverage, % of skin area 100 50 90 50 60
Classification Correct Incorrect Correct Incorrect Incorrect
B. Participant Assessments
Group Correct Classifications Incorrect Classifications
Live 40 1
Video 33 7
aTotal observations, n= 81.
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A. baumannii high-risk clones (CC79 and CC15) carrying
blaOXA-72 gene in 3 Brazilian states.
As part of a surveillance study performed by our research
group (Laboratório de Pesquisa em Resistência Bacteriana –
LABRESIS), we evaluated 94 A. baumannii-calcoaceticus
isolates from 4 Brazilian states (São Paulo, Rio de Janeiro, Rio
Grande do Sul, and Paraná) identified between April and
October 2013. The isolates were screened for oxacilinases genes
(ie, OXA-23, OXA-24/40, OXA-51, OXA-58, and OXA-143) by
polymerase chain reaction (PCR). Class 1 and 2 integrons were
detected by PCR for the integrase gene.3 Among these 94 isolates
from 3 states (São Paulo, Paraná and Rio Grande do Sul), 11
isolates (11.7%) presented positive results for the blaOXA-24/40,
which was identified by sequencing as the variant blaOXA-72
(ABI 3500 Genetic Analyzer). Species identification was
performed using matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF) and a gyrB
multiplex PCR, and all blaOXA-72–producing isolates were
identified as A. baumannii.
Clonal diversity of the A. baumanniiOXA-72 producers was
investigated using repetitive-sequence-based PCR (REP-
PCR).4 Results were interpreted according to a dendrogram
constructed using BioNumerics v6.5 software (bioMèrieux,
Marcy-l'Étoile, France). REP-PCR analysis showed the pre-
sence of 3 clonal groups (A, B, and C; Table 1).
The OXA-72 A. baumannii producers were typed using
the MLST scheme from the Pasteur Institute (http://www.
pasteur.fr). Analyses of the allele sequences and sequence
type (ST) were performed via the A. baumannii MLST
Institute Pasteur website (http://pubmlst.org/abaumannii/).
The relationships among the new and existing STs were eval-
uated using the eBURST program to determinate the clonal
relation of A. baumannii carrying blaOXA-72 among different
states. MLST demonstrated that the isolates belonged to 5
different sequence types: ST79, ST180, ST730, and the new
ST890 and ST891 (Table 1). According to the MLST data
analysis and the eBURST algorithm, the isolates belonged to
the epidemic clonal complexes CC15 (ST180 and ST890) and
CC79 (ST79 and ST730), and the ST891 was a singleton. CC15
was restricted to the state of Paraná, and CC79 was present in
Rio Grande do Sul and São Paulo states. Class 1 integrons were
detected in all isolates belonging to CC15, and all isolates of
CC79 presented class 2 integrons (Table 1).
Acinetobacter baumannii is characterized by a remarkable
capability to acquire antibiotic resistance determinants, intra-
and interhospital outbreaks, and national and international
clonal dissemination. Worldwide dissemination of multidrug-
resistant A. baumanniiOXA-23–producers has been associated
with specific clones, such as international clone 1 (CC1IP),
international clone 2 (CC2IP), and CC15IP.5 In Brazil, the
extensive dissemination of CC79 and CC15 have been
associated with blaOXA-23 production in different states.1,2
Furthermore, Stietz et al6 reported that ST79 is also frequently
observed among OXA-23–producing A. baumannii isolates in
Argentina, which demonstrates the dispersal of this CC79 not
only in Brazil but also in South America countries.6 The same
study demonstrated the spread of blaOXA-72 related to the
epidemic clone CC79.6
Acinetobacter baumannii belonging to CC15 have had evo-
lutionary success, and they usually exhibit multidrug-resistant
phenotypes, which has facilitated their rapid clonal expansion
in recent years. This clonal complex has been related to
OXA-23 outbreaks in several European countries, including
Italy, Spain, Greece, and Turkey, as well as an outbreak in
South America.5 To the best of our knowledge, this is the first
description of CC15 associated with OXA-72 production
reported in the literature.
The screening for integrase genes demonstrated the pre-
sence of class 1 and 2 integrons associated with CC15 and
CC79, respectively (Table 1). Interestingly, Martins et al7
showed the same distribution of class 1 and 2 integrons, related
to specific CCs such as CC15 and CC79.7 In a previous study,
we reported a high prevalence of class 2 integrons in southern
Brazil. Indeed, these results might be explained by the
association of class 2 integrons to CC79, which are prevalent in
South America.8
The OXA-72 enzyme was first identified in A. baumannii
from Thailand in 2004. Later, this enzyme was reported in
Acinetobacter spp. clinical isolates from China, South Korea,
Taiwan, Italy, Spain, and France.9 Until now, there have only
been a few reports of A. baumannii carrying the blaOXA-72
gene in Brazil.1 In the present study, we have described the
association of A. baumannii carrying blaOXA-72 with the
epidemic clones CC15, CC79, and a new ST (ST 891).
Camargo et al2 described blaOXA-72 producers of CC79 in
Brazil. In contrast, the data presented in our study have
demonstrated not only the association of blaOXA-72
producers to CC79 but also to CC15. The ability of these
particular clones to acquire antibiotic resistance should trigger
table 1. Molecular Typing Analysis of blaOXA-72–Producing
A. baumannii in Different Brazilian States
Isolate Location REP-PCR STa CCb Int
15POA Rio Grande do Sul A 730 79 Int2
16POA Rio Grande do Sul A 730 79 Int2
6SP São Paulo A 79 79 Int2
7SP São Paulo A 79 79 Int2
1PR Paraná B 180 15 Int1
7PR Paraná B 180 15 Int1
8PR Paraná B 180 15 Int1
9PR Paraná B 180 15 Int1
15PR Paraná B 180 15 Int1
17PR Paraná B 891 Singleton Int1
5PR Paraná C 890 15 Int1
NOTE. REP-PCR, repetitive-sequence–based polymerase chain
reaction; CC, clonal complex; ST, sequence type; MLST, multilocus
sequence typing; Int, integron.
aSequence type by Institute Pasteur MLST scheme.
bMLST clonal complex defined by Institute Pasteur.
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efforts to prevent the spread of OXA-72–producing isolates as
occurred with blaOXA-23.10 These data indicate the potential
for this gene to spread to different countries and distinct
geographical regions.
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A Silent Epidemic of Colistin- and
Carbapenem-Resistant Enterobacteriaceae at
a Turkish University Hospital
To the Editor—We read with great interest the manuscript
emphasizing increasing resistance to colistin and tigecycline
in Enterobacteriaceae.1 Hence, we present the epidemiology of
colistin- and carbapenem-resistant (CoCR) Klebsiella
pneumoniae (CoCR-KP) and Escherichia coli (CoCR-E. coli)
isolated from various clinical samples from January 1 through
July 30, 2015, at a 700-bed tertiary care university hospital. We
also report synergy testing results of antibiotic combinations
that could be used for the treatment of the infections caused
by CoCR isolates.
A total of 19 isolates (6 E. coli, 13 K. pneumoniae) from
17 patients were included in the study. All E. coli and
3 K. pneumoniae isolates were recovered from rectal swab
samples collected during a point prevalance program per-
formed for detection of CR-KP colonization in accordance
with Centers for Disease Control and Prevention methods.
Ten K. pneumoniae isolates were obtained from urine (n= 7),
blood (n= 1), central venous catheter (n= 1), and peritoneal
fluid (n= 1) samples. The identification of the isolates was
made by matrix-assisted laser desorption/ionization–time of
flight mass spectrometry (VITEK MS; bioMérieux) and by
analytical profile index (API20E; bioMérieux). Antimicrobial
susceptibility testing against carbapenem, colistin, and tigecy-
cline was performed by Etest (bioMérieux) and against
amikacin, gentamicin, cefuroxime, ceftazidime, cefepime,
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